Anne Altmeyer

990 total citations
17 papers, 848 citations indexed

About

Anne Altmeyer is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Anne Altmeyer has authored 17 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Anne Altmeyer's work include Immune Cell Function and Interaction (4 papers), Toxin Mechanisms and Immunotoxins (4 papers) and Biomarkers in Disease Mechanisms (3 papers). Anne Altmeyer is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Toxin Mechanisms and Immunotoxins (4 papers) and Biomarkers in Disease Mechanisms (3 papers). Anne Altmeyer collaborates with scholars based in United States, France and Switzerland. Anne Altmeyer's co-authors include Adam R. Goodman, J Vilček, Pramod K. Srivastava, Michael Heike, Robert G. Maki, Anna M. Feldweg, Sandra K. Masur, Hans‐Georg Wisniewski, Ruben Abagyan and Timothy Cardozo and has published in prestigious journals such as Journal of Biological Chemistry, Immunity and The Journal of Immunology.

In The Last Decade

Anne Altmeyer

17 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Altmeyer United States 11 439 360 220 99 86 17 848
H. Mann Germany 9 312 0.7× 225 0.6× 189 0.9× 115 1.2× 9 0.1× 21 813
Stefanie Loeser Austria 7 479 1.1× 341 0.9× 301 1.4× 29 0.3× 22 0.3× 7 813
G L Costa United States 8 218 0.5× 242 0.7× 99 0.5× 20 0.2× 12 0.1× 10 613
Iñigo Tirapu Spain 17 559 1.3× 213 0.6× 457 2.1× 17 0.2× 49 0.6× 32 888
Gaëlle Picarda France 15 195 0.4× 268 0.7× 186 0.8× 23 0.2× 24 0.3× 26 620
Carla Hebert United States 21 93 0.2× 884 2.5× 131 0.6× 143 1.4× 45 0.5× 32 1.2k
P. Emery United Kingdom 12 271 0.6× 332 0.9× 65 0.3× 42 0.4× 7 0.1× 12 700
Jonathan A. Hensel United States 14 234 0.5× 230 0.6× 307 1.4× 24 0.2× 11 0.1× 23 607
A Gobl Sweden 14 207 0.5× 228 0.6× 167 0.8× 37 0.4× 8 0.1× 22 616
H E Broxmeyer United States 14 392 0.9× 278 0.8× 346 1.6× 22 0.2× 7 0.1× 15 817

Countries citing papers authored by Anne Altmeyer

Since Specialization
Citations

This map shows the geographic impact of Anne Altmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Altmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Altmeyer more than expected).

Fields of papers citing papers by Anne Altmeyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Altmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Altmeyer. The network helps show where Anne Altmeyer may publish in the future.

Co-authorship network of co-authors of Anne Altmeyer

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Altmeyer. A scholar is included among the top collaborators of Anne Altmeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Altmeyer. Anne Altmeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Weitzman, Richard E., Nicholas Sauter, Erik Fink Eriksen, et al.. (2007). Critical review: Updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients—May 2006. Critical Reviews in Oncology/Hematology. 62(2). 148–152. 146 indexed citations
2.
Ursini‐Siegel, Josie, Wenli Zhang, Anne Altmeyer, et al.. (2002). TRAIL/Apo-2 Ligand Induces Primary Plasma Cell Apoptosis. The Journal of Immunology. 169(10). 5505–5513. 60 indexed citations
3.
Ménoret, Antoine, et al.. (2001). An Endoplasmic Reticulum Protein Implicated in Chaperoning Peptides to Major Histocompatibility of Class I Is an Aminopeptidase. Journal of Biological Chemistry. 276(36). 33313–33318. 49 indexed citations
4.
Dias, Adriana Abalen Martins, Adam R. Goodman, Jane Lima dos Santos, et al.. (2001). TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis. Journal of Leukocyte Biology. 69(6). 928–936. 116 indexed citations
5.
Altmeyer, Anne, et al.. (1997). Reversal of EBV Immortalization Precedes Apoptosis in IL-6–Induced Human B Cell Terminal Differentiation. Immunity. 7(5). 667–677. 52 indexed citations
6.
Goodman, Adam R., Timothy Cardozo, Ruben Abagyan, et al.. (1996). Long pentraxins: an emerging group of proteins with diverse functions. Cytokine & Growth Factor Reviews. 7(2). 191–202. 115 indexed citations
7.
Altmeyer, Anne, Robert G. Maki, Anna M. Feldweg, et al.. (1996). Tumor-specific cell surface expression of the -KDEL containing endoplasmic reticular heat shock protein gp96. International Journal of Cancer. 69(4). 340–349. 148 indexed citations
8.
Altmeyer, Anne, Lidija Klampfer, Adam R. Goodman, & J Vilček. (1995). Promoter Structure and Transcriptional Activation of the Murine TSG-14 Gene Encoding a Tumor Necrosis Factor/Interleukin-1-inducible Pentraxin Protein. Journal of Biological Chemistry. 270(43). 25584–25590. 73 indexed citations
9.
Dumont, Francis J., Anne Altmeyer, Paul Fischer, et al.. (1994). Relationship between multiple biologic effects of rapamycin and the inhibition of pp70S6 protein kinase activity. Analysis in mutant clones of a T cell lymphoma.. The Journal of Immunology. 152(3). 992–1003. 32 indexed citations
10.
Altmeyer, Anne & Francis J. Dumont. (1993). Rapamycin inhibits IL-1-mediated interferon-gamma production in the YAC-1 T cell lymphoma. Cytokine. 5(2). 133–143. 13 indexed citations
12.
Dumont, Francis J. & Anne Altmeyer. (1991). Modulation of IFN-mediated Ly-6E antigen induction by cAMP in a T cell lymphoma: Opposite effects on the responses to IFN-γ and IFN-. Cellular Immunology. 132(2). 466–480. 1 indexed citations
13.
Altmeyer, Anne, Paul Fischer, Philippe L. Durette, et al.. (1991). Unexpected up-regulation of gene expression by cyclosporin A and FK-506 in a T-cell lymphoma: Both immunosuppressants augment Ly-6E antigen induction by interferon-γ in the presence of ionomycin. International Journal of Immunopharmacology. 13(8). 1187–1199. 5 indexed citations
14.
Flattery, Amy, et al.. (1991). Up-regulation of gene expression by FK 506.. PubMed. 23(6). 2870–2. 3 indexed citations
15.
Dumont, Francis J., Anne Altmeyer, Mary Jo Staruch, et al.. (1990). Role of protein kinase C in IFN-mediated Ly-6E antigen induction.. The Journal of Immunology. 144(10). 3795–3803. 8 indexed citations
16.
Moog, Christiane, Bang Luu, Anne Altmeyer, & Pierre Bischoff. (1989). Studies on the immunosuppressive properties of 7,25 dihydroxycholesterol-II. Effects on early steps of T-cell activation. International Journal of Immunopharmacology. 11(5). 559–565. 20 indexed citations
17.
Altmeyer, Anne, Christiane Moog, Caroline Waltzinger, G. Hauptmann, & Pierre Bischoff. (1989). In vitro modulation of leucocyte-function-associated antigen-1 expression on two leukemic cell lines. Cancer Immunology Immunotherapy. 29(1). 29–34. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026